Study on the determination of pharmaceutical products containing amoxicillin and clavulanic acid by HPLC/DAD method
DOI:
https://doi.org/10.54939/1859-1043.j.mst.106.2025.102-112Keywords:
Amoxicillin; Clavulanate potassium; Solubility; Liquid chromatography (HPLC); Drug quality control.Abstract
Amoxicillin, a β-lactam antibiotic, is commonly combined with clavulanic acid to extend its antibacterial spectrum. Dissolution testing of pharmaceutical formulations containing these two substances has seldom been reported, largely due to the chemical instability of clavulanic acid and the analytical challenges of simultaneously quantifying both components. This lack of standardized methodology represents a significant research gap in the quality control of Amoxicillin/Clavulanate products. The objective of this study was to develop and validate a robust HPLC/DAD method for dissolution testing of the commercial formulation Vigentin. Dissolution was performed in ultrapure RO water (resistivity 18.2 MΩ·cm at 25 °C) under tightly controlled temperature and stirring speed. Chromatographic analysis employed a C18 column, a sodium dihydrogen phosphate/methanol (95:5, v/v) mobile phase, and UV detection at 220 nm. The validated procedure met all requirements for specificity, repeatability, and system suitability, with excellent linearity (R² > 0.9998). Dissolution quantification of six samples showed amoxicillin release between 93.9% and 98.9%, and potassium clavulanate between 103% and 107%, all above the minimum acceptance criterion of 75%. These results demonstrate that the proposed method effectively fills the methodological gap and provides a feasible, reliable tool for routine pharmaceutical quality evaluation of this clinically important drug combination.
References
[1]. Becze, A., Resz, M. A., Ilea, A., & Cadar, O. "A validated HPLC multichannel DAD method for the simultaneous determination of amoxicillin and doxycycline in pharmaceutical formulations and wastewater samples", Applied Sciences, 12(19), 9789, (2022). DOI: 10.3390/app12199789.
[2]. De Marco, B. A., Natori, J. S. H., Fanelli, S., Tótoli, E. G., & Salgado, H. R. N. "Characteristics, properties and analytical methods of amoxicillin: a review with green approach", Critical Reviews in Analytical Chemistry, 47(3), 267–277, (2017). DOI: 10.1080/10408347.2017.1281097.
[3]. Razuc, M. F. et al. "A new reliable and rapid HPLC method for the simultaneous determination of amoxicillin and sulbactam pivoxil in pharmaceuticals. Application to both assay and dissolution samples", Journal of Research in Pharmacy, 26(1), 123–135, (2025).
[4]. Dhull, P. et al. "Recent advances and application of liquid chromatography in pharmaceutical industry", Journal of Liquid Chromatography & Related Technologies, 1–20, (2025). DOI: 10.1080/10826076.2024.2448692.
[5]. Asan, A., & Seddıq, N. "A simple spectrophotometric determination of amoxicillin in drug samples", Journal of the Turkish Chemical Society Section A: Chemistry, 9(2), 423–432, (2022). DOI: 10.18596/jotcsa.978686.
[6]. Gülfen, M., Canbaz, Y., & Özdemir, A. "Simultaneous determination of amoxicillin, lansoprazole, and levofloxacin in pharmaceuticals by HPLC with UV–Vis detector", Journal of Analysis and Testing, 4, 45–53, (2020).
[7]. Foulstone, M., & Reading, C. "Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography", Antimicrobial Agents and Chemotherapy, 22(5), 753–762, (1982). DOI: 10.1128/AAC.22.5.753. PMID: 7181486; PMCID: PMC185656.
[8]. Tsou, T. L., Wu, J. R., Young, C. D., & Wang, T. M. "Simultaneous determination of amoxycillin and clavulanic acid in pharmaceutical products by HPLC with beta-cyclodextrin stationary phase", Journal of Pharmaceutical and Biomedical Analysis, 15(8), 1197–1205, (1997). DOI: 10.1016/S0731-7085(96)01960-7. PMID: 9215973.
[9]. Nguyen, C. T., & Tao, V. H. "Development of a simultaneous quantification procedure for amoxicillin and clavulanic acid using the UV-Vis spectrophotometric method", Journal of Science Research and Economic Development – Tay Do University, (14), 191–201, (2022).
[10]. Lieu, N. T., Le Thu Huong, V. T. H., & Tram, P. T. H. Y. "Determination of amoxicillin antibiotic residues in aquaculture wastewater by electrochemical method using a platinum nanoparticle electrode on a glassy carbon substrate", Journal of Science - Quy Nhon University, 16(1), 31–37, (2022).
[11]. Tran, T. B., Le, N. H. A., Tran, T. A. M., & Nguyen, T. Q. T. "Simultaneous determination of amoxicillin and clavulanic acid in antibiotic dose by spectrophotometry and chemometrics", Journal of Analysis in Chemistry, Physics, and Biology, 25(3), 9–15, (2020).
[12]. Sartorius. "Ultrapure water systems — product overview", Sartorius, (2025), https://www.sarto-rius.com/en/products/water-purification/ultrapure-water-systems.
[13]. United States Pharmacopeia (USP). “United States Pharmacopeia and National Formulary (USP 46–NF 41)”, United States Pharmacopeial Convention, Rockville, MD, (2023).
[14]. Vietnam Pharmacopoeia Council. “Vietnam Pharmacopoeia V, Appendix 12.2: General regulations on the quality control of herbal materials”, Ministry of Health, Hanoi, (2017).
[15]. Endashaw, E., Tatiparthi, R., Mohammed, T., et al. "Dissolution profile evaluation of selected brands of amoxicillin–clavulanate potassium tablets retailed in Hawassa town, Sidama Regional State, Ethiopia", AAPS Open, 10, 3, (2024). DOI: 10.1186/s41120-024-00091-2.
[16]. Waqas, M. K., Khan, H. U., Asghar, S., et al. "In vitro comparative dissolution assessment of different brands of Co-Amoxiclav tablets in Pakistan", Dissolution Technologies, 27(4), 6–12, (2020). DOI: 10.14227/DT270420PGC1.
[17]. Hoizey, G., Lamiable, D., Frances, C., et al. "Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC with UV detection", Journal of Pharmaceutical and Biomedical Analysis, 30(3), 661–666, (2002). DOI: 10.1016/S0731-7085(02)00289-3.
